Northwest & Ethical Investments’s Juno Therapeutics, Inc. JUNO Stock Holding History

Northwest & Ethical Investments’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,300	Closed	-$59.4K	–	375
2017 Q4	$59.4K	Buy	+1,300	New	+$64.8K	﹤0.01%	347

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Northwest & Ethical Investments's JUNO Position: Q1 2018 in Review

Northwest & Ethical Investments sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 1,300 shares — an estimated $59.4K sold.

Northwest & Ethical Investments first reported a position in JUNO in Q4 2017 and held it in 1 quarter. The position peaked at $59.4K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Northwest & Ethical Investments reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Northwest & Ethical Investments sold 1,300 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $59.4K.
Northwest & Ethical Investments first reported a position in Juno Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
Northwest & Ethical Investments's Juno Therapeutics, Inc. position peaked at $59.4K in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Northwest & Ethical Investments's 13F filing for Q1 2018, filed 8 Jul 2025.